These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613 [TBL] [Abstract][Full Text] [Related]
25. Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasia. Sena Esteves S; Cardoso C; Silva A; Abrunhosa J; Almeida E Sousa C Acta Otorrinolaringol Esp; 2016; 67(6):345-348. PubMed ID: 27079134 [TBL] [Abstract][Full Text] [Related]
26. [treatment of an epistaxis using a bilateral nasolabial flap in Osler-Rendu disease]. Benassayag C; Boudard P; Portmann D Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):305-7. PubMed ID: 8638056 [TBL] [Abstract][Full Text] [Related]
27. Resurfacing the nasomaxillary cavity for management of epistaxis in Osler-Rendu-Weber disease. Bedongi A; McCombe D; Kennedy J; Morrison W J Plast Reconstr Aesthet Surg; 2006; 59(5):537-40; discussion 536. PubMed ID: 16749201 [TBL] [Abstract][Full Text] [Related]
28. Guidelines of the French Society of Otorhinolaryngology (SFORL) (short version). Specific treatment of epistaxis in Rendu-Osler-Weber disease. Robard L; Michel J; Prulière Escabasse V; Bequignon E; Vérillaud B; Malard O; Crampette L; Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Feb; 134(1):37-41. PubMed ID: 27986467 [TBL] [Abstract][Full Text] [Related]
30. Natural history and control of epistaxis in a group of German patients with Rendu-Osler-Weber disease. Folz BJ; Tennie J; Lippert BM; Werner JA Rhinology; 2005 Mar; 43(1):40-6. PubMed ID: 15844501 [TBL] [Abstract][Full Text] [Related]
31. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Alden ME; Mohiuddin M Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448 [TBL] [Abstract][Full Text] [Related]
32. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial. Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329 [TBL] [Abstract][Full Text] [Related]
33. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis. Folz BJ; Wollstein AC; Lippert BM; Werner JA Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077 [TBL] [Abstract][Full Text] [Related]
34. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172 [TBL] [Abstract][Full Text] [Related]
35. Intranasal bevacizumab treatment on epistaxis in hereditary haemorrhagic telangiectasia: a case report. García-Martín E; Pernía-López S; Martínez-Ortega PA; Monje B; Ruiz-Martínez C; Sanjurjo-Saez M Eur J Hosp Pharm; 2019 Jul; 26(4):226-228. PubMed ID: 31338174 [TBL] [Abstract][Full Text] [Related]
36. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355 [TBL] [Abstract][Full Text] [Related]
37. [Reconstruction of the nasal septum combined with septal dermoplasty in Rendu-Osler-Weber's disease (author's transl)]. Kastenbauer ER Laryngol Rhinol Otol (Stuttg); 1977 Nov; 56(11):890-4. PubMed ID: 145523 [TBL] [Abstract][Full Text] [Related]
38. [The use of superselective embolization of the maxillary artery in treatment of bleedings in the Rendu-Osler-Weber syndrome]. Kantor I; Winiarski M; Jurkiewicz D; Osiecki M; Brzozowski K Otolaryngol Pol; 2005; 59(2):215-7. PubMed ID: 16095090 [TBL] [Abstract][Full Text] [Related]
39. [Bilateral closure of the nasal cavity. An original surgical technique of treatment of severe recurrent epistaxis in Rendu-Osler disease]. Serrano E; Percodani J; Pessey JJ Ann Otolaryngol Chir Cervicofac; 1998 Jun; 115(3):169-73. PubMed ID: 9765720 [TBL] [Abstract][Full Text] [Related]
40. [Histopathology and therapy of severe epistaxis in Rendu-Osler disease]. KINDLER W; TIEDEMANN R Arch Ohren Nasen Kehlkopfheilkd; 1956; 168(6):441-60. PubMed ID: 13340846 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]